Background and Aim: Cervical cancer is the seventh most frequent cancer worldwide but more than 80% of cases occur in developing countries. This study was carried out to evaluate the results of combining radiotherapy and/or chemotherapy with regional hyperthermia on advanced cervical cancer (FIGO ⅢA~ⅢB). Methods: The study used new medical instrument was the first step of demonstrating the curative value against cervical cancer in DPR Korea. The medical instrument has been named as Hyperthermia instrument-NAMSUN -413 based on dielectric heating principle. Results: After Hyperthermia (HT group) and irradiation (TRT group) alone, 0% and 2.3% of patients showed complete response (CR) respectively, but in thermochemotherapy (HT+CT group) and thermoradiotherapy (HT+TRT group) CR rate increased to 23.5% and 25.0% respectively. HT+CT and HT+TRT during the treatment resulted in the acceptable side effects due to cisplatin or irradiation. Conclusion: As a result of our data, hyperthermia, as an adjuvant with radiation and chemotherapy can be used to treat the advanced cervical cancer.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: